Here is the rundown on market activity for HealthEquity, Inc. (NASDAQ:HQY). President and CEO Jon Kessler sold 150,000 shares at an average price of $50.27 on June 7th. The President and CEO now owns $21,113,400 of the stock as reported to the SEC. Stephen Neeleman, Founder and Vice Chairman reported the sale of 40,000 shares of HQY stock. The shares were purchased at an average price of $51.45. The Founder and Vice Chairman now owns $38,602,163 of the stock per the Form 4 SEC filing.
Ashley Dreier, Executive VP, CTO and CIO disclosed the sale of 10,000 shares of (HQY). The shares were sold on June 5th for an average price of $47.93. Dreier now owns $270,900 of the stock according to the SEC filing.
HealthEquity, Inc., launched on October 18, 2002, is a provider of a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is involved in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions. The Business’s platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives and make educated investment choices to help in their tax-advantaged healthcare savings..
These firms have also modified their investment in HQY. Clearbridge Investments, LLC grew its ownership by buying 540 shares an increase of 85.0% as of 03/31/2017. Clearbridge Investments, LLC owns 1,175 shares with a value of $50,000. The total value of its holdings increased 92.3%. As of the end of the quarter Morgan Stanley had disposed of 499 shares trimming its position 31.3%. The value in dollars went from $65,000 to $47,000 a change of $18,000 quarter to quarter.
Tower Research Capital LLC (trc) reduced its investment by shedding 389 shares a decrease of 69.8% in the quarter. Tower Research Capital LLC (trc) claims 168 shares valued at $7,000. The value of the position overall is down by 69.6%. Goldman Sachs Group Inc expanded its stake by buying 58,341 shares an increase of 772.0%. Goldman Sachs Group Inc currently owns 65,898 shares worth $2,797,000. The value of the position overall is up by 814.1%.
On December 13, 2016 Chardan Capital starting coverage on HQY with an initial rating of “Buy”. JP Morgan starting coverage on the stock setting a rating of “Overweight”.
On September 12 Raymond James left the stock rating at “Outperform” and raised the price target to $40.00 from $24.00. September 7 investment analysts at Baird maintained a stock rating of “Neutral” but raised the price expectation from $29.00 to $35.00.
April 4 investment analysts at Leerink Swann made no change to the company rating of “Outperform” but moved up the price target from $26.00 to $30.00. On March 23 Barrington Research made no change to the stock rating of “Outperform” but raised the price target to $30.00 from $24.00.
The company is down by -4.53% since yesterday’s close of $54.47. The stock last traded at $52.00 which is just over the 50 day moving average which is $46.06 and which is marginally over the 200 day moving average of $44.09. The 50 day moving average was up by +12.89% and the 200 day average went up $7.91 or +17.94%.
The P/E ratio is 118.18 and the market cap of the company is 3.10B. As of the last earnings report the EPS was $0.44 and is estimated to be $0.57 for the current year with 59,628,000 shares outstanding. Next quarter’s EPS is forecasted at $0.13 and the next full year EPS is projected to be $0.70.
Investors are more bullish of late if you take into consideration the downtick in short interest. The stock saw a fall in short interest of -16.34% as of May 15, 2017 from the last reporting period. Short shares fell 622,662 over that timeframe. Days to cover increased 1.1 to 8.9 and the percentage of shorted shares was 0.05% on May 15.